GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ERK-2 with hypothemycin covalently bound

Analyse Crystal structure of ERK-2 with hypothemycin covalently bound in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3C9W
Type
protein
Length
672 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
HMY
Pockets
9 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33639% helix, 15% strandP63086

Ligands and binding sites

  • HMY · (1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13440.640.7933HMY
22730.610.7933HMY
3630.410.8018empty
41060.390.7623empty
5860.390.7720empty

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 3C9W · Crystal Structure of ERK-2 with hypothemycin covalently bound · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.